SCHEMBL24116169

SCHEMBL24116169

CCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2[C@@H](O)[C@H](O)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 18/20 0.66
▸ CNR1 P21554 16/20 0.66
▸ TRPA1 O75762 1/20 0.51
▸ CYP1A1 P04798 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2A6 P11509 1/20 0.51
▸ CYP2B6 P20813 1/20 0.51
▸ SLC6A2 P23975 1/20 0.51
▸ HTR2A P28223 1/20 0.51
▸ SLC6A4 P31645 1/20 0.51
▸ OPRM1 P35372 1/20 0.51
▸ CYP2J2 P51589 1/20 0.51
▸ CYP1B1 Q16678 1/20 0.51
▸ TRPV1 Q8NER1 1/20 0.51
▸ TRPV3 Q8NET8 1/20 0.51
▸ TRPV4 Q9HBA0 1/20 0.51
▸ TRPV2 Q9Y5S1 1/20 0.51
▸ ABHD12 Q8N2K0 3/20 0.45
▸ ABHD6 Q9BV23 3/20 0.45
▸ FAAH O00519 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545974 0.92 CNR2 (0.68) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL16917973 0.92 CNR2 (0.68) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL31545703 0.92 CNR2 (0.68) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL11758846 0.87 CNR2 (0.70) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL11778160 0.86 CNR2 (0.66) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL31545389 0.83 CNR2 (0.65) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL22916046 0.82 CNR2 (0.77) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL20911332 0.82 CNR2 (0.77) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL13214138 0.82 CNR2 (0.77) CNR2CNR1TRPA1CYP1A1CYP1A2
SCHEMBL29353562 0.82 CNR2 (0.77) CNR2CNR1TRPA1CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393575-A1 N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID BASED COMPOSITIONS RECEPTOR HOLDINGS, INC. (US) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393575-A1 N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID BASED COMPOSITIONS FAAH, CNR2, FABP2 CNR2 2/4885CNR1 5/4885TRPA1 871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback